Baseline Severity of Disease by Scapular Dyskinesia Stage^1. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

Subjects:

Patient Demographics. by James M. Friedman (22522150)

Subjects:

Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

Subjects:

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

Subjects:

Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop (central). by James M. Friedman (22522150)

Subjects:

Sample Pain Diagrams. by James M. Friedman (22522150)

Subjects:

Patient Example. by James M. Friedman (22522150)

Subjects:

Scores of Burnout, Resilience, and PTS Over Time. by Rachel G. Baskin (22127334)

Subjects:

RM-ANOVA Post hoc Testing for PTS Across Time. by Rachel G. Baskin (22127334)

Subjects:

Results of longitudinal analysis of mental health in HCWs. by A. H. Ayesha Lavell (16734002)

Mean scores and 95% CI of mental health symptoms, COVID-19 admissions and effect size during follow-up. by A. H. Ayesha Lavell (16734002)

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Graphs showing reproduction of selected South American annual case (a) and death (b) data using 1000 parameter sets drawn from post-burn-in distribution obtained from 4 Markov chai... by Keith Fraser (1868587)

Subjects:

Modelled seroprevalence estimates (coloured regions) compared with real data (black). by Keith Fraser (1868587)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects:

Comparison of the blood culture contamination rate (per set) in each organism between the control and bundle periods. by Miki Doi (15347878)

Subjects:

Reasons for the determination of blood culture contamination for each organism. by Miki Doi (15347878)

Subjects:

Protocol for blood culture during the control period. by Miki Doi (15347878)

Subjects: